July 29 Webinar to showcase research using hospital CDW and HIRA DataC&R Research will host its 7th webinar on July 29 under the theme, "Exploring RWD∙RWE in Database-Based PMS∙OS Studies: How Far Can We Go?"The webinar will explore the use of hospital CDW and HIRA data in post-marketing research.For more details, please refer to the link below.Read the text | Ref: Pharmnews

    Combining AI-Driven CRO Capabilities to Explore New Business OpportunitiesC&R Research has signed an MOU with Taimei Intelligence R&D to expand its global clinical research business.Leveraging Taimei Group's global network, the two companies will conduct local roadshows and pursue new global clinical trial opportunities.By combining AI-driven capabilities with CRO expertise, they aim to build a two-way platform connecting the Chinese and global markets while jointly developing new business opportunities.For more details, please refer to the link below.Read the text | Ref: Newspim

    Transforming into a Global AI-Driven BusinessIn a recent interview, C&R Research outlined its vision of becoming a global Top 20 CRO.Through global expansion and its transformation into a data-driven platform,the company aims to create new growth opportunities and strengthen its position in the global market.For more details, please refer to the link below.Read the text | Ref: Bizwatch

Advancing Global Clinical Evidence for U.S. FDA ApprovalC&R Research has secured the U.S. confirmatory clinical trial for 'Somzz',Korea’s first authorized digital therapeutic(DTx).Conducted in collaboration withC&R Research’s Medical Device Team, its U.S. subsidiary, and Trial Informatics,the project supports FDA approval and U.S. market entry while demonstrating the company’s global clinical trial capabilities.For more details, please refer to the link below.Read the text | Ref: Edaily

Exploring Global Regulatory Perspectives and Practical ApplicationsC&R Research hosts its 6th webinar on June 24,“Making Bayesian Work in Clinical Trials: Regulatory Perspectives and Practical Insights.”The webinar explores FDA and EMA regulatory perspectives andpractical applications of Bayesian methods in clinical research.For more details, please refer to the link below.Read the text | Ref: Hankyung

KRW 18.3 Billion in Cumulative orders since Indonesia Branch LaunchC&R Research signed an additional global Phase 3 clinical trial contract worth approximately KRW 5 billion with Daewoong Pharmaceutical,bringing its cumulative global order volume to KRW 18.3 billion based on its multinational clinical trial capabilities centered in Indonesia.Accordingly, the company is expected to further strengthen its position as an “Asian Global CRO” based on the network it has built across Asia.For more details, please refer to the link below.Read the text | Ref: Edaily